Instadose Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2021	FY 2020
Period Ending	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Net Income	-0.46	-0.03
Other Operating Activities	0.38	0.03
Change in Accounts Payable	0.01	-0
Change in Other Net Operating Assets	0.07	-
Operating Cash Flow	-0	-0
Short-Term Debt Issued	-	0
Total Debt Issued	-	0
Net Debt Issued (Repaid)	-	0
Financing Cash Flow	-	0
Net Cash Flow	-0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.